DK1248776T3 - Semi-syntetiske taxaner med antitumor og antiangiogene aktiviteter - Google Patents

Semi-syntetiske taxaner med antitumor og antiangiogene aktiviteter

Info

Publication number
DK1248776T3
DK1248776T3 DK01905668T DK01905668T DK1248776T3 DK 1248776 T3 DK1248776 T3 DK 1248776T3 DK 01905668 T DK01905668 T DK 01905668T DK 01905668 T DK01905668 T DK 01905668T DK 1248776 T3 DK1248776 T3 DK 1248776T3
Authority
DK
Denmark
Prior art keywords
del
ins
sup
delete
date
Prior art date
Application number
DK01905668T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Alessandro Pontiroli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1248776T3 publication Critical patent/DK1248776T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01905668T 2000-01-18 2001-01-15 Semi-syntetiske taxaner med antitumor og antiangiogene aktiviteter DK1248776T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000056A IT1317731B1 (it) 2000-01-18 2000-01-18 Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.
EP01905668A EP1248776B1 (en) 2000-01-18 2001-01-15 Semi-synthetic taxanes with antitumor and antiangiogenetic activities

Publications (1)

Publication Number Publication Date
DK1248776T3 true DK1248776T3 (da) 2004-11-22

Family

ID=11443708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01905668T DK1248776T3 (da) 2000-01-18 2001-01-15 Semi-syntetiske taxaner med antitumor og antiangiogene aktiviteter

Country Status (24)

Country Link
US (2) US6589979B2 (cs)
EP (1) EP1248776B1 (cs)
JP (1) JP4986354B2 (cs)
KR (1) KR100813704B1 (cs)
CN (1) CN1176916C (cs)
AT (1) ATE271044T1 (cs)
AU (1) AU781650B2 (cs)
CA (1) CA2397591C (cs)
CZ (1) CZ301251B6 (cs)
DE (1) DE60104281T2 (cs)
DK (1) DK1248776T3 (cs)
ES (1) ES2223778T3 (cs)
HK (1) HK1049998B (cs)
HU (1) HU229347B1 (cs)
IL (1) IL150787A0 (cs)
IT (1) IT1317731B1 (cs)
NO (1) NO329403B1 (cs)
PL (1) PL202591B1 (cs)
PT (1) PT1248776E (cs)
RU (1) RU2259363C2 (cs)
SI (1) SI1248776T1 (cs)
SK (1) SK285683B6 (cs)
TR (1) TR200401811T4 (cs)
WO (1) WO2001053282A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688415A1 (en) * 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
ITMI20050415A1 (it) * 2005-03-15 2006-09-16 Indena Spa Derivati tassanici semi-sintetici ad attivita' antitumorale
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FI3122757T3 (fi) 2014-02-28 2023-10-10 Hangzhou Dac Biotech Co Ltd Varautuneita linkkereitä ja niiden konjugointikäyttötapoja
EP3319936B1 (en) 2015-07-12 2025-12-17 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
AU2016429272A1 (en) 2016-11-14 2019-05-02 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
HU222496B1 (hu) * 1994-07-26 2003-07-28 Indena S.P.A. Félszintetikus taxánszármazékok, eljárás ezek előállítására, valamint ezeket tartalmazó gyógyászati készítmények

Also Published As

Publication number Publication date
ITMI20000056A0 (it) 2000-01-18
CA2397591A1 (en) 2001-07-26
ES2223778T3 (es) 2005-03-01
NO329403B1 (no) 2010-10-11
CZ301251B6 (cs) 2009-12-23
HUP0204344A3 (en) 2004-01-28
DE60104281D1 (de) 2004-08-19
NO20023428D0 (no) 2002-07-17
CZ20022478A3 (cs) 2002-10-16
SK285683B6 (sk) 2007-06-07
US20030028038A1 (en) 2003-02-06
PL356272A1 (en) 2004-06-28
JP2003520792A (ja) 2003-07-08
WO2001053282A1 (en) 2001-07-26
TR200401811T4 (tr) 2004-09-21
HK1049998A1 (en) 2003-06-06
RU2259363C2 (ru) 2005-08-27
AU781650B2 (en) 2005-06-02
USRE39723E1 (en) 2007-07-10
AU3369401A (en) 2001-07-31
SI1248776T1 (en) 2004-10-31
US6589979B2 (en) 2003-07-08
ATE271044T1 (de) 2004-07-15
IT1317731B1 (it) 2003-07-15
EP1248776A1 (en) 2002-10-16
KR100813704B1 (ko) 2008-03-13
JP4986354B2 (ja) 2012-07-25
NO20023428L (no) 2002-09-16
PL202591B1 (pl) 2009-07-31
EP1248776B1 (en) 2004-07-14
SK10562002A3 (sk) 2002-11-06
PT1248776E (pt) 2004-10-29
RU2002119060A (ru) 2004-01-10
KR20020068082A (ko) 2002-08-24
HU229347B1 (hu) 2013-11-28
HUP0204344A2 (en) 2003-05-28
CN1395571A (zh) 2003-02-05
CN1176916C (zh) 2004-11-24
CA2397591C (en) 2009-10-20
HK1049998B (zh) 2005-04-01
IL150787A0 (en) 2003-02-12
DE60104281T2 (de) 2005-08-18
ITMI20000056A1 (it) 2001-07-18

Similar Documents

Publication Publication Date Title
RU2365372C2 (ru) Циклические ингибиторы протеинтирозинкиназ
DE60318177D1 (de) Rho-kinase inhibitoren
TR200200717T2 (tr) Terapötik kinazolin türevleri.
DE602004024900D1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
MY134783A (en) Rho-kinase inhibitors
MY142915A (en) Rho-kinase inhibitors
IS6865A (is) Setnar alkýlamínafleiður og aðferðir við notkun þeirra
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
DE602004015810D1 (de) Substituierte isochinolinderivate und anwendungsverfahren
PT1017675E (pt) Derivados da camtotecina altamente lipofilos
YU22702A (sh) Derivati indolil-3-glioksilne kiseline sa terapeutski vrednim svojstvima
MY129310A (en) C-4 carbonate taxanes
MXPA04004219A (es) Derivados de quinazolina como agentes antitumorales.
ATE238981T1 (de) Antitumorwirkstoffe
NO20024076D0 (no) Sammensetning omfattende camptotecin og et pyrimidinderivat for behandling av cancer
NO20023428D0 (no) Semisyntetiske taksaner med antitumor og antiangiogene aktiviteter
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
ATE390923T1 (de) Topoisomerase-giftmittel
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
DK1549329T3 (da) Ekstrakt med antitumoraktivitet og anti-giftaktivitet
EE200200681A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
EE200200660A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
DK1572715T3 (da) Steroidforbindelser med antitumor-aktivitet
FR2908131B1 (fr) Derives d'aminobenzocycloheptene,leurs procedes de preparation et leur utilisation en therapeutique